Adalta Capital Management LLC Syros Pharmaceuticals, Inc. Transaction History

Adalta Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$5.55 - $11.34 $88,383 - $180,589	-15,925 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$10.16 - $13.65 $7,874 - $10,578	775 Added 5.12%	15,925 $163,000
Q1 2018 May 16, 2018	BUY	$9.47 - $12.98 $35,701 - $48,934	3,770 Added 33.13%	15,150 $197,000
Q4 2017 Feb 14, 2018	BUY	$8.45 - $17.48 $96,160 - $198,922	11,380	11,380 $111,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.25M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Adalta Capital Management LLC with notifications on news.